First they made the mice live longer. Now they'll see if the mice live better.
Researchers at the University of Texas Health Science Center are getting a $5.2 million grant to look into the potential age-defying effects of rapamycin.
“This could be groundbreaking in treating aging and age-related diseases,” said Arlan Richardson, director of the Barshop Institute for Longevity and Aging Studies.
Read more of Elizabeth Allen's article at http://www.mysanantonio.com/health/63556022.html